WHO flags 11% Kovid -19 positivity rate with new version NB.1.8.1
Which has reported an increase in global covid-19 cases, test positivity has reached 11%. The new version nb.1.8.1 is spreading rapidly, increasing concerns over monitoring and vaccine coverage.

In short
- Global Kovid -19 Test Positivity Rate reaches 11%since July 2024
- Infections from mid-February affect the Eastern Mediterranean Sea and Southeast Asia
- The new version nb.1.8.1 accounts for more than 10% of global sequences
The World Health Organization (WHO) has reported a fresh lift in the global COVID-19 activity, the test positivity rate has reached 11%, not a level has been observed since July 2024.
According to the latest data collected from the Sentinel monitoring sites, the increase in infection has been the most clear from the middle of February 2025, which affects many areas including Eastern Mediterranean, South-East Asia and Western Pacific.
The growth also matches the major Sars-Cov-2 variants with subtle changes.
While the circulation of the LP.8.1 version has declined in recent months, the new NB.1.8.1 Strain, which is currently listed as a version under monitoring, is receiving the ground, has been reported as mid-May for accounting for 10.7% global sequences.
Despite the increase in activity, those who said that the trends are largely corresponding to the pattern seen around the same time last year.
However, the organization insisted that Covid-19 still does not demonstrate a clear seasonal pattern, and the global monitoring is inconsistent.
The WHO said in its latest update, “SARS-COV-2 variants and continuous monitoring of transmission are necessary, especially the monitoring capabilities have been reduced in many areas.”
The WHO has reiterated the importance of continuous efforts in the Kovid -19 management, called the countries to adopt “Risk -based, Integrated Officers” mentioned in permanent recommendations issued by the Director General of WHO.
Vaccination is central for this strategy. The WHO urged countries to prioritize vaccine coverage, especially among high -risk groups, to hospitalize and reduce deaths.
Health experts have repeatedly expressed concern over the decline in Covid-19 testing and genome sequencing globally, those trends have made it more difficult to detect and respond to new variants in real time.
With any defined seasonal cycle installed by the health agency, the development of the virus challenges the traditional outbreak forecast.